Surgery Godfather
Chapter 1058 - 868 Doing Good Deeds But Still Being Hated

Chapter 1058: Chapter 868 Doing Good Deeds But Still Being Hated

After Lan Xueping was admitted to the inpatient department, Yang Ping instructed the physician in charge to expedite the completion of the patient’s examinations.

Yang Ping had never attempted this new method in reality, so after the examinations were completed, he planned to invite Professor Deng to jointly develop the surgery plan.

Before retirement, Professor Deng worked at the Temple of Heaven Hospital in Beijing, which has the nation’s best neurosurgery department. Discussing this type of new surgery with the experienced professor was not only a form of respect but also a necessary procedure.

Head Nurse Cai’s ankle showed no signs of recovery, but her daily tasks couldn’t be performed while merely sitting still, such as the afternoon nurse rounds, which she also needed to attend.

What to do?

Xia Shu had no choice but to push her in a wheelchair, so the scene during the afternoon nurse rounds was quite odd—a man pushing the head nurse, followed by a dozen nurses for the rounds.

Yang Ping watched Xia Shu from a distance, who seemed willing enough, and appeared quite accepting of this task.

Nie Shun’e was preparing for discharge and bought another basket of fruit as a gift for the doctors and nurses, even presenting one specifically to Yang Ping. The couple personally expressed their gratitude to Yang Ping, even bowing respectfully—it was exceedingly polite of them.

They planned to start their business on the sky bridge of Sanbo Hospital after discharge, so they decided to rent an apartment first and move in once they had settled on a place.

Pan Doudou was quickly transferred out of the ICU. She was very stable post-surgery, prompting Director Fang to bring two baskets of cherries to the Surgical Research Institute. He also took a walk around the department to see if anyone needed help, clearly considering himself an adjunct member of the team.

When Director Fang saw Xia Shu pushing the head nurse, he immediately volunteered, "Dr. Xia, take a break, let me push."

At this, all the nurses’ eyes were fixed on Director Fang. Those weren’t just gazes; they were more like arrows, as if they were ready to devour him. What was happening? How could doing a good deed attract such hate? Could social morals have decayed this much?

Director Fang instinctively stepped back, unsure of what he had done wrong, and could only stand in the corridor pondering over life.

Yang Ping went back to the doctors’ office to rest for a while before entering the System Space Laboratory. The efficiency of the System Space was very high; the electron microscope photography of dead tumor cells was already complete, and the billions of pictures were impossible to process by manpower.

Fortunately, the system panel served as a supercomputer, and although its computing power was far less than the computer Yang Ping was promised as a future reward, it was sufficient for now.

Yang Ping handed over the task of comparing and analyzing the images to the System Panel and began to focus on the newly cultivated muscle.

Under the guidance of the Spatial Orientation Gene, the stem cells had formed not just a pile of scattered cells but a complete piece of muscle.

Moreover, as control over other parameters became clearer, the success rate of cultivation kept increasing, with a stable rate above eighty percent.

After identifying the first Spatial Orientation Gene, Yang Ping turned his attention to the next one. He was determined to find the Spatial Orientation Gene for cartilage because, compared to complex organs like the heart, Yang Ping believed that the development control of muscle and cartilage was simple and straightforward.

For complex organs like the heart, there might be more than one guiding gene, and their regulatory mechanisms were undoubtedly intricate.

Start with the simple things and work step by step.

---

A laboratory of a certain American company.

As the transparent glass cover opened, Dr. Connell, wearing gloves, carefully took out the cultivator from inside, and regretfully, it had failed again, he shook his head in disappointment.

He had anticipated this result because as the experiment progressed to this point, he had become very baffled, with no breakthrough in basic research, it was no longer possible to move forward.

However, the company had high expectations for this technology, and as the saying goes, the greater the expectations, the greater the disappointment.

No matter how stem cell technology developed, in the end, it cultivated cells, not organs, a heap of scattered cells, not shaped organs.

The technique Dr. Connell had created, using scaffolds to guide the crawling of cells, was not much different from biological 3D printing, both using external scaffolds to manipulate and stack cells.

The scaffold crawling technique had not made a breakthrough, and biological 3D printing technology was still lingering in the same spot.

The printed miniature organs could only be used for experiments such as drug research, and were not yet applicable to clinical settings, because they were not actual organs; strictly speaking, they were just "organs" formed by stacking cells in the shape of an organ, lacking the microstructure of organs.

Dr. Connell knew that although the progress of the experiments was slow, they now possessed the world’s most advanced stem cell technology, at least ten years ahead of anyone else.

The company had bet heavily on this, listing stem cell technology as one of the few strategic technologies for future dominance in biotechnology.

An assistant at the side said, "Recently, a Chinese doctor published several articles mentioning new concepts like microscopic dissection and spatial orientation genes. If we could really understand the microscopic anatomy of organs, wouldn’t that be a great help to the experiments?"

Dr. Connell shook his head; he had read those papers too:

"The spatial orientation gene is just a hypothesis, which so far no experiment has been able to verify. It’s a hypothesis that is too advanced, offering no help to current research." "If we go down this path, we would face an enormous amount of data, first needing to decode the stem cells’ genes, then find a way to distinguish these genes. This project would be more enormous than atomic bomb research or the moon landing, and the cost of trial and error is incalculable. And this is still just a hypothesis."

"Do you think Boeing Company would invest in researching the so-called curvature engine?"

The assistant understood: indeed, a hypothesis that was too advanced was hard to prove.

"What about microscopic dissection? I think it has a strong practicality! Coupled with the appropriate biological 3D printing technology, using biological 3D printing to replicate organs could be a very good path." The assistant was clearly a fan of Yang Ping.

Dr. Connell still shook his head:

"Similarly, while it seems possible, it’s actually very difficult. The threshold is high because to truly understand microscopic dissection, we need to establish a digital human based on microscopic dissection; this would require a huge number of bodily tissue sections to collect data, then participation from supercomputers; the initial data collection is massive, and a single laboratory would hardly manage it. Abandoning a mature path to start anew on an unfamiliar and potentially impassable one, what do you think a smart person would choose?"

The assistant had an epiphany once again.

"Mr. Connell, you needn’t be upset. In fact, in regenerative medicine, we are already ahead. No one can catch up to us. We hold the entire core technology in our hands, we have technologically blocked the whole world, the barriers we’ve built over the years are getting higher and higher, even if we gave them our laboratory data, they wouldn’t understand it, let alone surpass us," the assistant consoled Dr. Connell.

Regenerative medicine, anti-tumor, and the technologies derived from them are the core technologies of the future biopharmaceutical industry. Whoever controls these technologies can control the future of the medical industry, so the company has invested heavily in this area.

PS: I’ll just post the draft today, I’m still not over a cold I’ve been battling for a few days. I’ll revise it when I have time tomorrow, thank you all.